North Chicago, IL, June 22, 2026 (PR Newswire) -- AbbVie has agreed to acquire Apogee Therapeutics in a transaction valued at approximately $1.8 billion. The acquisition adds promising immunology programs that complement AbbVie’s existing portfolio and strengthen its pipeline in immune-mediated diseases. The deal is intended to enhance AbbVie’s long-term growth strategy and expand its capabilities in next-generation immunology therapies. Read full article here.

Cambridge, MA, June 29, 2026 (Business Wire) -- Pixee Medical has named Kristoff Goson as chief executive officer to lead its next phase of growth in the United States. Goson will oversee the company’s strategy to expand commercialization of its orthopedic navigation technologies and strengthen its presence in the U.S. market. The appointment reflects Pixee Medical’s focus on scaling operations and driving broader adoption of its digital surgery solutions. Read full article

Darmstadt, Germany, June 25, 2026 (PR Newswire) -- Merck KGaA has agreed to acquire Bio-Techne in a transaction valued at approximately $17 billion. The acquisition is intended to strengthen Merck’s position in rapidly growing life sciences markets by adding complementary technologies and capabilities. The deal supports the company’s strategy to expand its global presence and enhance its portfolio of research and bioprocessing solutions. Read full article here.

Wilmington, NC, June 8, 2026 (Reuters) -- Incyte has struck a collaboration agreement valued at up to $2 billion with a subsidiary of Star Therapeutics. The deal is structured around upfront funding and milestone-based payments tied to development progress. It is aimed at broadening Incyte’s pipeline with new therapeutic candidates and strengthening its long-term growth strategy. Read full article here.

Gaithersburg, MD, June 16, 2026 (Business Wire) -- GeneDx has named Mark Gardner as its new president. The appointment is intended to support the company’s next phase of scaling its genomics and precision diagnostics business. GeneDx aims to accelerate operational growth and expand its market reach under the new leadership. Read full article here.

Bedford, MA, June 9, 2026 (Novanta) -- Novanta has announced the acquisition of Riverpoint Medical to strengthen its healthcare and surgical solutions portfolio. The transaction expands Novanta’s capabilities in serving medical device customers with specialized technologies. The acquisition supports the company’s strategy to broaden its offerings and accelerate long-term growth in healthcare markets. Read full article here.

New Britain, PA, June 15, 2026 (PR.com) -- Thrombolex has appointed Michael Tutera as chief executive officer following a planned leadership transition. Co-founder and former CEO Mike Cerminaro will remain involved as a member of the board of directors. The company expects Tutera’s commercial and operational experience to support broader adoption of its endovascular catheter platform and drive the next stage of growth. Read full article here.

London, June 9, 2026 (GSK) -- GSK has entered an agreement to acquire Nuvalent in a transaction valued at $10.6 billion. The acquisition adds late-stage targeted oncology assets focused on lung cancer and expands GSK’s precision medicine capabilities. The deal is intended to accelerate growth in oncology and strengthen the company’s long-term pipeline strategy. Read full article here.

San Francisco, CA and Boston, MA, May 27, 2026 (Globe Newswire) -- Apogee Therapeutics has entered a strategic financing collaboration with Blackstone Life Sciences valued at $1.3 billion. The agreement will support Phase 3 development and potential commercialization of its immunology candidate zumilokibart. The funding is intended to accelerate late-stage clinical progress and prepare the program for possible market launch. Read full article here.

Springdale, AR, May 28, 2026 (PR Newswire) -- NOWDiagnostics has appointed Lisa Nibauer as its new chief executive officer. The leadership change is intended to guide the company’s next phase of innovation and organizational transformation. NOWDiagnostics aims to accelerate development and commercialization of its diagnostic technologies under the new leadership. Read full article here.

South San Francisco, CA, June 2, 2026 (NewLimit) -- NewLimit has secured $435 million in funding in a round led by Founders Fund to accelerate development of its longevity-focused platform. The capital will support advancement of programs aimed at reprogramming cells to address age-related diseases. The financing is expected to expand research capabilities and advance the company’s long-term therapeutic pipeline. Read full article here.

Exton, PA, June 1, 2026 (PR Newswire) -- West Pharmaceutical Services has appointed Michel Lagarde as its new president and chief executive officer. The leadership transition is intended to guide the company’s strategic direction and operational execution. West aims to continue expanding its global pharmaceutical packaging and delivery systems business under new leadership. Read full article here.